Study of Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody to Treat Non-hodgkin's Lymphoma

NCT01459887 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

278

Enrollment

INDUSTRY

Sponsor class

Conditions

Diffuse Large B Cell Lymphoma

Interventions

DRUG: CHOP combined with CMAB304
DRUG: CHOP, CMAB304

Sponsor

Shanghai CP Guojian Pharmaceutical Co., Ltd.